Vitaly Margulis
Papers
2
Total Citations
6
H-Index
2
About
Vitaly Margulis is a urologic oncologist whose research centers on upper tract urothelial carcinoma (UTUC), a complex and relatively rare malignancy of the renal pelvis and ureter. Working within the ROBUUST 2.0 Collaborative Group, an international consortium dedicated to advancing the understanding of high-risk UTUC, Margulis has made meaningful contributions to both surgical and systemic treatment decision-making for this disease. His work on pretreatment nomograms represents a significant clinical tool, offering surgeons and oncologists a data-driven framework for predicting muscle invasion prior to radical nephroureterectomy — a finding with direct implications for selecting optimal treatment strategies. Equally impactful is his investigation into adjuvant immunotherapy outcomes, addressing an area of active debate in the field: whether immune checkpoint inhibitors meaningfully improve survival in high-risk UTUC patients following surgery. Though his most recent publications are early in their citation trajectory — reflecting their 2025 publication dates — they already demonstrate measurable scholarly uptake. Margulis's research exemplifies a rigorous, collaborative approach to rare genitourinary cancers, bridging pathological insight with evolving systemic therapies to improve outcomes for a historically underserved patient population.
Research Focus
Key Achievements
Top Papers
- 1
- 2